Bullous Pemphigoid Associated With Linagliptin Treatment

JAMA Dermatol. 2016 Feb;152(2):224-6. doi: 10.1001/jamadermatol.2015.2939.

Authors

Roger Haber¹, Alice Mouna Fayad¹, Farid Stephan¹, Grace Obeid², Roland Tomb¹

Affiliations

¹ Department of Dermatology, Hotel Dieu de France University Hospital, Beirut, Lebanon2Faculty of Medicine, Saint Joseph University, Beirut Lebanon.
² Department of Dermatology, Sacre Coeur Hospital, Beirut, Lebanon.

PMID: 26465961
DOI: 10.1001/jamadermatol.2015.2939

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Diabetes Mellitus, Type 2 / drug therapy
Dipeptidyl-Peptidase IV Inhibitors / administration & dosage
Dipeptidyl-Peptidase IV Inhibitors / adverse effects*
Female
Humans
Linagliptin / administration & dosage
Linagliptin / adverse effects*
Male
Middle Aged
Pemphigoid, Bullous / chemically induced*
Pemphigoid, Bullous / pathology

Substances

Dipeptidyl-Peptidase IV Inhibitors
Linagliptin